Farms.com Home   News

Stats Can releases November production of principal field crops report

Canadian farmers reported producing more corn for grain and soybeans, but less wheat, canola, barley, and oats in 2023. Lower production for most crops was driven largely by lower yields, especially in Western Canada where growing conditions were generally drier than in 2022.

Throughout the growing season in 2023, dry conditions across much of Western Canada contributed to lower yields compared with 2022. Warm and dry conditions allowed farm operators to complete harvests in a timely manner across most of the prairies. In parts of Eastern Canada, adequate moisture and warm temperatures resulted in good yields, although some parts of Quebec and the Atlantic provinces may have been affected by above-average precipitation.

Wheat harvest decreases on lower yield

Total wheat production fell by 6.9% to 32.0 million tonnes in 2023, attributable to lower production in the Prairies, likely because of dry conditions. Lower yields (-12.1% to 44.5 bushels per acre) offset the higher harvested area (+6.0% to 26.4 million acres).

Saskatchewan wheat production fell by 6.7% to 14.2 million tonnes. Yields decreased by 12.4% to 37.5 bushels per acre, offsetting higher harvested area, which rose by 6.4% to 14.0 million acres.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.